Condition
Severe Anemia
Total Trials
8
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 8 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
4 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
P 3 (2)
P 4 (2)
Trial Status
Not Yet Recruiting3
Unknown2
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Showing 8 of 8 trials
NCT07523646Phase 4Not Yet Recruiting
Anemia Therapy in Patients With Infective Endocarditis
NCT06624631Phase 4Recruiting
PDMC Implementation Trial in Kenya
NCT06345417Not Yet RecruitingPrimary
Outcomes of Patient Blood Management in Severely Anemic Patients
NCT06345469Not Yet RecruitingPrimary
Cost Analysis of Therapies for Severe Anemia
NCT02494297Completed
DUS on the Prescribing Indications for CPA/EE in 5 European Countries
NCT02671175Phase 3Completed
Post-discharge Malaria Chemoprevention(PMC) Study
NCT02483650Unknown
Hyperbaric Oxygen Therapy Registry
NCT02721420Phase 3Unknown
Delivery of Malaria Chemoprevention in the Post-discharge Management of Children With Severe Anaemia in Malawi
Showing all 8 trials